Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Oral drug improves platelet recovery during chemotherapy in gastrointestinal cancer patients

An oral medication already approved for thrombocytopenia in patients with liver disease significantly improved platelet recovery and helped patients with gastrointestinal cancers maintain platelet counts needed to continue chemotherapy as scheduled, according to results from a phase 2 clinical trial led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and Mass General Hospital.

21 May 2026

Experimental virus therapy targets resistant high-grade neuroendocrine tumors

A phase I clinical trial is testing whether a tumor-targeting virus can help immunotherapy work more effectively against aggressive neuroendocrine tumors that often resist treatment.

21 May 2026

Artificial intelligence-based tool could improve multiple myeloma treatment decisions

An artificial intelligence-based tool may help physicians determine which newly diagnosed multiple myeloma patients are most likely to benefit from specific therapies, including immunotherapy and stem cell transplantation.

21 May 2026

Specific gene fusion patterns tied to solitary fibrous tumor outcomes

Specific genetic fusion patterns in solitary fibrous tumors may help identify which patients face a higher risk of metastasis, recurrence and more aggressive disease behavior, according to new research that could improve how physicians assess and eventually treat this rare cancer.

21 May 2026

Vitamin B12 analog targets deadly brain cancer cells

A new research paper was published in Volume 13 of Oncoscience on April 2, 2026, titled "Selective blood–brain barrier penetration and tumor targeting of nitrosylcobalamin in glioblastoma: Pharmacokinetics, tissue distribution, and synergistic activity with trail and temozolomide."

21 May 2026

Researchers discover unexpected cellular triggers for precancerous pancreas lesions

In an unexpected finding, a new study flips on its head researchers' understanding of how precancerous pancreas lesions evolve into pancreatic cancer.

21 May 2026

Targeting tumor-specific inflammatory process may prevent drug resistance in colon cancer

Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse.

21 May 2026

Structured approach to a healthy lifestyle may help slow important aspects of aging

Researchers at Wake Forest University School of Medicine found evidence of slowed aging from lifestyle behaviors like healthy eating and exercise as part of a major clinical trial.

21 May 2026

New gene expression signature may guide immunotherapy for resistant prostate cancer patients

Researchers with the James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center have discovered a new gene expression signature within tumors that can help identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are more likely to experience lasting benefits from combined immunotherapy treatment.

21 May 2026

Engineered nanomaterials optimize delivery barriers in cancer immunotherapy

Cancer immunotherapy works by mobilizing the body's own immune system to recognize and destroy malignant cells.

20 May 2026

Scientists uncover why genome guardian p53 protein is uniquely prone to collapse

The protein p53 is often called the guardian of the genome for its central role in preventing cancer. Yet paradoxically, it is also one of the most frequently mutated and dysfunctional proteins in human tumors.

20 May 2026

Study reveals cellular mechanisms driving resistance to targeted cancer therapies

Despite impressive innovations in medicine, most advanced-stage cancers still carry a grim prognosis. Developing more effective treatments requires a deeper understanding of the cellular processes that drive the formation and growth of common cancers.

20 May 2026

Click chemistry advances precision oncology by merging imaging and therapyly

Conventional cancer treatments like chemotherapy often struggle with poor targeting, leading to severe systemic toxicity and drug resistance.

19 May 2026

Davis Joseph wins international award for revolutionary cancer treatment discovery

The Sustainability through Science and Technology Summit 2025 (SIPS 2025), celebrating its 21st edition in Cebu, Philippines, from 17–20 November 2025, presented the 2025 Ciechanover International Biology Award to Davis Joseph.

19 May 2026

Molecular profiling initiative seeks to uncover late breast cancer recurrence mysteries

The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN), in collaboration with the SWOG Cancer Research Network (SWOG), has launched a new initiative to analyze paired original and recurrent tumor specimens from two practice-changing breast cancer clinical trials.

19 May 2026

MIDAS platform accelerates protein engineering through rapid PCR-based screening

Proteins are critical to life – and to industry. There are countless proteins that could be engineered to treat and even cure serious diseases and cellular dysfunctions.

19 May 2026

AI avatar doctor reduces stress for cancer patients before consultations

Cancer patients who interact with an artificial intelligence (AI) avatar doctor before they meet their real-life consultant feel more knowledgeable and less stressed, according to research presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026)

18 May 2026

Blood test detects tumor DNA to guide advanced cancer treatment

A blood test that detects tumor DNA circulating in the bloodstream may help select the most effective treatment options for cancer patients whose tumors have started to spread, according to one of the largest randomized controlled trials of its kind presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026).

18 May 2026

International trial proves AI can design gold-standard cancer treatment plans

An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer, according to results from a large international trial led by researchers at University College London (UCL) and the London School of Hygiene & Tropical Medicine (LSHTM).

18 May 2026

Targeted radiotherapy may delay progression in metastatic breast cancer patients

Treating breast cancer that has begun to spread around the body with targeted radiotherapy could help patients to live longer without their cancer getting worse, according to the results of a small randomised controlled trial presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026).

17 May 2026

Previous
1
...
15
16
17
18
19
20
21
...
1248
Next

Oncology News and Research

Further Reading

Oral drug improves platelet recovery during chemotherapy in gastrointestinal cancer patients

Experimental virus therapy targets resistant high-grade neuroendocrine tumors

Artificial intelligence-based tool could improve multiple myeloma treatment decisions

Specific gene fusion patterns tied to solitary fibrous tumor outcomes

Vitamin B12 analog targets deadly brain cancer cells

Researchers discover unexpected cellular triggers for precancerous pancreas lesions

Targeting tumor-specific inflammatory process may prevent drug resistance in colon cancer

Structured approach to a healthy lifestyle may help slow important aspects of aging

New gene expression signature may guide immunotherapy for resistant prostate cancer patients

Engineered nanomaterials optimize delivery barriers in cancer immunotherapy

Scientists uncover why genome guardian p53 protein is uniquely prone to collapse

Study reveals cellular mechanisms driving resistance to targeted cancer therapies

Click chemistry advances precision oncology by merging imaging and therapyly

Davis Joseph wins international award for revolutionary cancer treatment discovery

Molecular profiling initiative seeks to uncover late breast cancer recurrence mysteries

MIDAS platform accelerates protein engineering through rapid PCR-based screening

AI avatar doctor reduces stress for cancer patients before consultations

Blood test detects tumor DNA to guide advanced cancer treatment

International trial proves AI can design gold-standard cancer treatment plans

Targeted radiotherapy may delay progression in metastatic breast cancer patients

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News